{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:17:43Z","timestamp":1783459063241,"version":"3.55.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,6]],"date-time":"2027-07-06T00:00:00Z","timestamp":1814832000000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaip.2026.02.039","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:19:42Z","timestamp":1783329582000},"page":"1477-1488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4055-7391","authenticated-orcid":false,"given":"Chen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Durkee-Shock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Adrian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulbu","family":"Uzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.02.039_bib1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/ACI.0000000000000689","article-title":"Primary immune regulatory disorders: a growing universe of immune dysregulation","volume":"20","author":"Chan","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.039_bib3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaci.2020.08.022","article-title":"Efficacy and economics of targeted panel versus whole exome sequencing in 878 patients with suspected primary immunodeficiency","volume":"147","author":"Platt","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib4","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jaci.2025.07.001","article-title":"Inborn errors of regulatory T-cell differentiation and function","volume":"156","author":"Oktelik","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.anai.2021.03.005","article-title":"State-of-the-art diagnostic evaluation of common variable immunodeficiency","volume":"127","author":"Lee","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jaip.2026.02.039_bib7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2026.02.039_bib8","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jaip.2026.02.039_bib9","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib10","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib11","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2019.11.043","article-title":"Treatment with rapamycin can restore regulatory T-cell function in IPEX patients","volume":"145","author":"Passerini","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2015-07-657981","article-title":"Sirolimus is effective in relapsed\/refractory autoimmune cytopenias: results of a prospective multi-institutional trial","volume":"127","author":"Bride","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.02.039_bib14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/bjd.19124","article-title":"Dermatological adverse events associated with use of oral mechanistic target of rapamycin inhibitors in a cohort of individuals with tuberous sclerosis complex","volume":"183","author":"Pithadia","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2026.02.039_bib15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.TP.0000151630.25127.3A","article-title":"Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy","volume":"79","author":"Mah\u00e9","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jaip.2026.02.039_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/jamadermatol.2020.5180","article-title":"Mucocutaneous adverse events associated with oral sirolimus for the treatment of vascular anomalies","volume":"157","author":"Grenier","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2026.02.039_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2036.2003.01386.x","article-title":"Pharmacokinetics of budesonide controlled ileal release capsules in children and adults with active Crohn\u2019s disease","volume":"17","author":"Lundin","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaip.2026.02.039_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.immuni.2006.03.001","article-title":"CTLA4Ig: bridging the basic immunology with clinical application","volume":"24","author":"Bluestone","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2026.02.039_bib19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","article-title":"Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial","volume":"378","author":"Orban","year":"2011","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jaip.2026.02.039_bib20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2337\/dc22-2200","article-title":"Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: a randomized, double-masked, controlled trial","volume":"46","author":"Russell","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaip.2026.02.039_bib21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.immuni.2025.03.004","article-title":"Soluble CTLA-4 regulates immune homeostasis and promotes resolution of inflammation by suppressing type 1 but allowing type 2 immunity","volume":"58","author":"Osaki","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2026.02.039_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcph.1308","article-title":"Population pharmacokinetics and exposure-response relationship of intravenous and subcutaneous abatacept in patients with rheumatoid arthritis","volume":"59","author":"Li","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2026.02.039_bib23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2021.04.039","article-title":"Therapeutic options for CTLA-4 insufficiency","volume":"149","author":"Egg","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.gastro.2012.04.010","article-title":"Abatacept for Crohn\u2019s disease and ulcerative colitis","volume":"143","author":"Sandborn","year":"2012","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.jaip.2026.02.039_bib25","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1182\/blood-2018-99-120185","article-title":"Management of cytopenias in CTLA4 haploinsufficiency using abatacept and sirolimus","volume":"132","author":"Uzel","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.02.039_bib26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jaip.2020.12.024","article-title":"Mapping out autoimmunity control in primary immune regulatory disorders","volume":"9","author":"Farmer","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.039_bib27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1182\/blood.2021013496","article-title":"Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects","volume":"139","author":"Dhunputh","year":"2022","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.jaip.2026.02.039_bib28","article-title":"Dosing dilemmas in CTLA4 haploinsufficiency","volume":"131","author":"Jaroenpuntaruk","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/j.gastro.2015.04.016","article-title":"Loss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitis","volume":"149","author":"Brandse","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2026.02.039_bib30","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jaci.2017.05.022","article-title":"Exaggerated follicular helper T-cell responses in patients with LRBA deficiency caused by failure of CTLA4-mediated regulation","volume":"141","author":"Alroqi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.adh8342","article-title":"Microbiota-dependent activation of CD4+ T cells induces CTLA-4 blockade-associated colitis via Fc\u03b3 receptors","volume":"383","author":"Lo","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.jaip.2026.02.039_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40168-025-02028-7","article-title":"The intestinal microbiome and metabolome discern disease severity in cytotoxic T-lymphocyte-associated protein 4 deficiency","volume":"13","author":"Chandrasekaran","year":"2025","journal-title":"Microbiome"},{"key":"10.1016\/j.jaip.2026.02.039_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10875-022-01379-2","article-title":"Interferon-driven immune dysregulation in common variable immunodeficiency-associated villous atrophy and norovirus infection","volume":"43","author":"Strohmeier","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib34","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1038\/s41467-023-41798-2","article-title":"Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23\/IFN\u03b3 axis","volume":"14","author":"Lo","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2026.02.039_bib35","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s10875-023-01569-6","article-title":"JAK inhibition with baricitinib for severe CVID-related enteropathy: a case report","volume":"43","author":"Abdelmoumen","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaip.2026.02.039_bib37","doi-asserted-by":"crossref","DOI":"10.1097\/PG9.0000000000000099","article-title":"CTLA-4 haploinsufficiency presenting as extensive enteropathy in a patient with very early onset inflammatory bowel disease","volume":"2","author":"Tran","year":"2021","journal-title":"JPGN Rep"},{"key":"10.1016\/j.jaip.2026.02.039_bib38","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1038\/s41598-022-10777-w","article-title":"Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database","volume":"12","author":"Hoisnard","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2026.02.039_bib39","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1038\/s41467-020-16491-3","article-title":"Human norovirus targets enteroendocrine epithelial cells in the small intestine","volume":"11","author":"Green","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2026.02.039_bib40","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/infdis\/jiae398","article-title":"Reconstitution of norovirus-specific T-cell responses following hematopoietic stem cell transplantation in patients with inborn errors of immunity and chronic norovirus infection","volume":"231","author":"Durkee-Shock","year":"2025","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.039_bib41","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.jaip.2025.02.026","article-title":"Chronic norovirus infection in immunodeficiency: a UK national case series","volume":"13","author":"Grammatikos","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.039_bib42","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1182\/bloodadvances.2024013727","article-title":"Harnessing viral-specific T cells: expanding therapeutic strategies across diverse populations","volume":"9","author":"Djassemi","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaip.2026.02.039_bib43","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1172\/JCI135947","article-title":"Haploinsufficiency of immune checkpoint receptor CTLA4 induces a distinct neuroinflammatory disorder","volume":"130","author":"Schindler","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaip.2026.02.039_bib44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jaip.2026.02.039_bib45","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1038\/s41467-019-10812-x","article-title":"Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis","volume":"10","author":"Serwas","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2026.02.039_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2015.09.025","article-title":"The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency","volume":"137","author":"G\u00e1mez-D\u00edaz","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib47","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jaip.2026.02.039_bib48","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jaci.2025.04.003","article-title":"Lipopolysaccharide-responsive and beige-like anchor protein (LRBA) functional deficiency caused by biallelic LRBA missense variants characterized by Evans syndrome or colitis","volume":"156","author":"Chiang","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib49","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2026.02.039_bib50","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00262-015-1729-x","article-title":"Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry","volume":"64","author":"Santegoets","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaip.2026.02.039_bib51","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.jaci.2023.08.004","article-title":"Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency","volume":"152","author":"Taghizade","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib52","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jaci.2017.04.023","article-title":"Treatment of severe forms of LPS-responsive beige-like anchor protein deficiency with allogeneic hematopoietic stem cell transplantation","volume":"141","author":"Seidel","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib53","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jaci.2019.12.896","article-title":"Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score","volume":"145","author":"Tesch","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib54","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.jaip.2022.01.042","article-title":"Morbidity, mortality, and therapeutics in combined immunodeficiency: data from the USIDNET registry","volume":"10","author":"Durkee-Shock","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.039_bib55","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/s41467-020-18925-4","article-title":"Early-onset autoimmunity associated with SOCS1 haploinsufficiency","volume":"11","author":"Hadjadj","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2026.02.039_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.680334","article-title":"One gene, many facets: multiple immune pathway dysregulation in SOCS1 haploinsufficiency","volume":"12","author":"K\u00f6rholz","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib57","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/S2665-9913(24)00348-5","article-title":"Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based study","volume":"7","author":"Hadjadj","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaip.2026.02.039_bib58","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib59","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/ACI.0000000000001039","article-title":"STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders","volume":"24","author":"Olbrich","year":"2024","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaci.2023.10.018","article-title":"JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: an ESID\/EBMT-IEWP retrospective study","volume":"153","author":"Fischer","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib61","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3389\/fimmu.2018.02012","article-title":"Increased risk for malignancies in 131 affected CTLA4 mutation carriers","volume":"9","author":"Egg","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib62","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s10875-019-00677-6","article-title":"A Spectrum of clinical findings from ALPS to CVID: several novel LRBA defects","volume":"39","author":"Cagdas","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib63","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13023-017-0682-5","article-title":"Multifocal gastric adenocarcinoma in a patient with LRBA deficiency","volume":"12","author":"Bratani\u010d","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaip.2026.02.039_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/cei.13600","article-title":"Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: a systematic review","volume":"205","author":"Jamee","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib65","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13075-019-1992-x","article-title":"Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study","volume":"21","author":"Simon","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaip.2026.02.039_bib66","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.02.039_bib67","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40257-022-00701-3","article-title":"JAK in the [black] box: a dermatology perspective on systemic JAK inhibitor safety","volume":"23","author":"Elmariah","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaip.2026.02.039_bib68","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.46336","article-title":"Use of biologic or targeted synthetic disease-modifying antirheumatic drugs and cancer risk","volume":"7","author":"Sendaydiego","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2026.02.039_bib69","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.transproceed.2007.08.078","article-title":"Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies","volume":"39","author":"Boraty\u0144ska","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaip.2026.02.039_bib70","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1200\/JCO.2008.17.7279","article-title":"Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning","volume":"26","author":"Armand","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaip.2026.02.039_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2026.02.039_bib72","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/jcm11020322","article-title":"Sirolimus-based immunosuppression is associated with decreased incidence of post-transplant lymphoproliferative disorder after heart transplantation: a double-center study","volume":"11","author":"Asleh","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaip.2026.02.039_bib73","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi\u2019s sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.02.039_bib74","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s10875-020-00804-8","article-title":"Everolimus-induced remission of classic Kaposi\u2019s sarcoma secondary to cryptic splicing mediated CTLA4 haploinsufficiency","volume":"40","author":"Yap","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib75","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2249.2008.03711.x","article-title":"Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia","volume":"153","author":"Ward","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib76","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10875-013-9873-6","article-title":"Nodular regenerative hyperplasia in common variable immunodeficiency","volume":"33","author":"Fuss","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib77","article-title":"Link between persistent, unexplained gamma-glutamyltransferase elevation and porto-sinusoidal vascular disorder","volume":"6","author":"Pugliese","year":"2024","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.jaip.2026.02.039_bib78","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.dld.2019.05.016","article-title":"Liver stiffness assessment by transient elastography suggests high prevalence of liver involvement in common variable immunodeficiency","volume":"51","author":"Crescenzi","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaip.2026.02.039_bib79","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s10875-022-01319-0","article-title":"Evaluation of laboratory and sonographic parameters for detection of portal hypertension in patients with common variable immunodeficiency","volume":"42","author":"Globig","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.933463","article-title":"Liver disease accompanied by enteropathy in common variable immunodeficiency: common pathophysiological mechanisms","volume":"13","author":"Lima","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib81","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.jaip.2019.04.016","article-title":"Liver disease is common in patients with common variable immunodeficiency and predicts mortality in the presence of cirrhosis or portal hypertension","volume":"7","author":"Azzu","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.039_bib82","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/hep.32539","article-title":"Tip of the iceberg: a comprehensive review of liver disease in inborn errors of immunity","volume":"76","author":"Sharma","year":"2022","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jaip.2026.02.039_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1259246","article-title":"Hepatic stellate cell-intrinsic role of SOCS1 in controlling hepatic fibrogenic response and the pro-inflammatory macrophage compartment during liver fibrosis","volume":"14","author":"Kandhi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.02.039_bib84","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(19)30047-0","article-title":"Porto-sinusoidal vascular disease: proposal and description of a novel entity","volume":"4","author":"De Gottardi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2026.02.039_bib85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/lt.24979","article-title":"Liver transplantation in adults with liver disease due to common variable immunodeficiency leads to early recurrent disease and poor outcome","volume":"24","author":"Azzu","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jaip.2026.02.039_bib86","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/hep.31775","article-title":"Recurrent nodular regenerative hyperplasia post-liver transplantation in common variable immunodeficiency","volume":"74","author":"Hercun","year":"2021","journal-title":"Hepatol Baltim Md"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826003259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826003259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:48:45Z","timestamp":1783457325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826003259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":85,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2213219826003259"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.02.039","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}